Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,668 | 161 | 96.5% |
| Education | $95.86 | 6 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $437.84 | 32 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $345.16 | 23 | $0 (2017) |
| Bayer Healthcare Pharmaceuticals Inc. | $253.77 | 15 | $0 (2024) |
| Travere Therapeutics, Inc. | $181.83 | 11 | $0 (2024) |
| Mylan Specialty L.P. | $169.17 | 12 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $160.60 | 11 | $0 (2021) |
| Mallinckrodt Enterprises LLC | $160.10 | 10 | $0 (2019) |
| Relypsa, Inc. | $133.84 | 8 | $0 (2020) |
| Mauna Kea Technologies, Inc. | $126.67 | 7 | $0 (2023) |
| Baxter Healthcare | $119.21 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $365.55 | 17 | Novartis Pharmaceuticals Corporation ($113.84) |
| 2023 | $196.78 | 12 | Travere Therapeutics, Inc. ($69.96) |
| 2022 | $103.67 | 6 | Mauna Kea Technologies, Inc. ($43.36) |
| 2021 | $286.08 | 16 | Horizon Therapeutics plc ($79.51) |
| 2020 | $241.27 | 14 | Mallinckrodt Hospital Products Inc. ($70.55) |
| 2019 | $412.26 | 24 | Boehringer Ingelheim Pharmaceuticals, Inc. ($88.15) |
| 2018 | $453.29 | 30 | Boehringer Ingelheim Pharmaceuticals, Inc. ($135.53) |
| 2017 | $704.98 | 48 | Sunovion Pharmaceuticals Inc. ($345.16) |
All Payment Transactions
167 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $23.27 | General |
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $25.10 | General |
| 10/10/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $32.33 | General |
| 10/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Cardio-renal | ||||||
| 09/26/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $31.32 | General |
| 09/26/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 08/29/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $24.10 | General |
| 08/22/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Hyperkalemia | ||||||
| 06/25/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 04/09/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 04/02/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $25.25 | General |
| 03/07/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $34.14 | General |
| 03/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Cardio-renal | ||||||
| 02/26/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $24.74 | General |
| 02/15/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Genetic Disease | ||||||
| 11/07/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $24.02 | General |
| 11/07/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 11/07/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.66 | General |
| 10/12/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Cardio-renal | ||||||
| 10/09/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Diabetes | ||||||
| 10/05/2023 | Mauna Kea Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $22.54 | General |
| 07/13/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Inflammation | ||||||
| 03/31/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $22.22 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 985 | 3,871 | $508,130 | $181,851 |
| 2022 | 25 | 1,381 | 12,030 | $648,175 | $251,285 |
| 2021 | 20 | 1,221 | 8,323 | $403,230 | $236,675 |
| 2020 | 21 | 1,149 | 6,905 | $411,966 | $212,656 |
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 37 | 185 | $148,555 | $48,689 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 426 | 540 | $117,312 | $44,990 | 38.4% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 17 | 110 | $70,290 | $23,099 | 32.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 78 | 272 | $28,016 | $15,688 | 56.0% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2023 | 52 | 2,224 | $53,376 | $15,246 | 28.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 34 | 56 | $36,848 | $11,951 | 32.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 79 | 109 | $21,255 | $9,922 | 46.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 41 | $12,372 | $4,761 | 38.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 170 | 243 | $3,340 | $2,041 | 61.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $5,540 | $1,986 | 35.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 15 | 34 | $7,292 | $1,832 | 25.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 13 | $3,731 | $1,565 | 41.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 23 | 24 | $203.00 | $81.84 | 40.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 47 | 228 | $183,084 | $61,154 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 391 | 555 | $100,380 | $47,788 | 47.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 48 | 113 | $64,620 | $25,049 | 38.8% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 17 | 107 | $66,301 | $23,688 | 35.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 108 | 413 | $42,699 | $21,630 | 50.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 68 | 74 | $21,290 | $10,316 | 48.5% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2022 | 39 | 1,414 | $33,012 | $10,168 | 30.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 77 | 102 | $19,922 | $9,804 | 49.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 60 | $15,116 | $7,566 | 50.1% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 35 | 44 | $22,900 | $6,733 | 29.4% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 11 | 74 | $10,931 | $4,739 | 43.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 34 | 77 | $13,698 | $4,167 | 30.4% |
About Dr. Grant Mathews, MD
Dr. Grant Mathews, MD is a Internal Medicine healthcare provider based in Mountain Home, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1689898843.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Grant Mathews, MD has received a total of $2,764 in payments from pharmaceutical and medical device companies, with $365.55 received in 2024. These payments were reported across 167 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,668).
As a Medicare-enrolled provider, Mathews has provided services to 4,736 Medicare beneficiaries, totaling 31,129 services with total Medicare billing of $882,467. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Mountain Home, AR
- Active Since 04/12/2007
- Last Updated 10/16/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689898843
Products in Payments
- OFEV (Drug) $282.42
- ACTHAR (Biological) $230.65
- UTIBRON (Drug) $214.92
- Kerendia (Drug) $174.06
- Veltassa (Drug) $166.32
- BROVANA (Drug) $130.24
- LOKELMA (Drug) $119.64
- KRYSTEXXA (Biological) $114.31
- OPSUMIT MACITENTAN (Drug) $82.47
- Adempas (Drug) $79.71
- Dymista (Drug) $69.27
- STIOLTO (Drug) $64.53
- SAMSCA (Drug) $61.20
- TAVNEOS (Drug) $60.68
- Yupelri (Drug) $58.94
- STIOLTO RESPIMAT (Drug) $41.22
- Perforomist (Drug) $40.96
- JARDIANCE (Drug) $36.49
- Renal - PD (Device) $35.14
- Renal - CRRT (Device) $29.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mountain Home
Dr. Paul Provance, M.d, M.D
Internal Medicine — Payments: $4,615
Thomas Helton, D.o, D.O
Internal Medicine — Payments: $4,409
Dr. Lance Lincoln, M.d, M.D
Internal Medicine — Payments: $3,378
Dr. Peter Li, Md, MD
Internal Medicine — Payments: $2,408
Saad Hijazi, Md, MD
Internal Medicine — Payments: $2,238
Dr. Bryan Watson, D.o, D.O
Internal Medicine — Payments: $1,994